Last edition
News about "DNA Polymerase IIIC Inhibitors"
USPTO Issues New Patent to Acurx for DNA Polymerase IIIC Inhibitor Technology
The newly granted patent covers DNA polymerase IIIC inhibitors, including compositions of matter, methods of use and pharmaceutical formulations, further strengthening Acurx’s Intellectual Property (IP) portfolio and expanding its growing patent estate in the US and international markets.
DNA Polymerase IIIC Inhibitors | 03/02/2026 | By News Bureau
Acurx Pharmaceuticals Secures Japanese Patent for DNA Polymerase IIIC Inhibitors
Acurx Pharmaceuticals has secured a new patent from the Japanese Patent Office for its DNA Polymerase IIIC Inhibitors, expanding its global intellectual property portfolio in antimicrobial drug development.
DNA Polymerase IIIC Inhibitors | 20/02/2025 | By Abha | 247
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy